IMC Chicago LLC Decreases Position in Direxion Daily S&P Biotech Bull 3x Shares $LABU

IMC Chicago LLC lowered its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) by 64.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,645 shares of the company’s stock after selling 26,015 shares during the quarter. IMC Chicago LLC owned about 0.40% of Direxion Daily S&P Biotech Bull 3x Shares worth $2,334,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of LABU. Qube Research & Technologies Ltd purchased a new stake in Direxion Daily S&P Biotech Bull 3x Shares during the 2nd quarter worth approximately $26,000. Headlands Technologies LLC purchased a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the second quarter worth $69,000. Bank of America Corp DE raised its holdings in shares of Direxion Daily S&P Biotech Bull 3x Shares by 134.2% in the third quarter. Bank of America Corp DE now owns 2,476 shares of the company’s stock worth $232,000 after buying an additional 1,419 shares during the last quarter. Group One Trading LLC acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the third quarter worth $349,000. Finally, CIBC Private Wealth Group LLC acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the third quarter worth $351,000.

Direxion Daily S&P Biotech Bull 3x Shares Price Performance

NYSEARCA LABU opened at $173.61 on Friday. The stock’s fifty day moving average price is $170.39 and its 200 day moving average price is $159.10. Direxion Daily S&P Biotech Bull 3x Shares has a 1 year low of $44.69 and a 1 year high of $212.45.

Direxion Daily S&P Biotech Bull 3x Shares Company Profile

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.